In aging or end-stage liver disease, hepatic dysfunction, along with a reduction in growth hormone (GH) receptors, leads to decreased serum levels of insulin-like growth factor 1 (IGF-1) (57). This evidence concerns the gene IGF1 and End Stage Liver Disease.